Semarion introduces SemaCyte Multiplexing Platform to enhance cell assay data quality and speed during drug discovery Post author: Post published:March 20, 2024 Post category:uncategorized Post Content You Might Also Like Why some heavy drinkers develop advanced liver disease, while others do not February 6, 2025 Revolutionizing brain tumor treatment: the rise of AI in neuro-oncology April 2, 2024 Study links air pollution with increased Alzheimer’s markers February 21, 2024